Cresco Labs Inc.
CL
CNSX
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -67.43M | -172.46M | -154.66M | -175.52M | -339.49M |
Total Depreciation and Amortization | 72.31M | 72.70M | 71.95M | 69.30M | 63.43M |
Total Amortization of Deferred Charges | 4.81M | 4.68M | 4.55M | 4.42M | 4.29M |
Total Other Non-Cash Items | 88.06M | 196.65M | 148.73M | 145.15M | 284.35M |
Change in Net Operating Assets | 1.93M | -10.62M | 21.20M | 15.22M | 52.92M |
Cash from Operations | 99.69M | 90.95M | 91.77M | 58.56M | 65.50M |
Capital Expenditure | -21.11M | -27.49M | -38.62M | -55.39M | -63.70M |
Sale of Property, Plant, and Equipment | 7.04M | 7.20M | 12.06M | 11.70M | 5.45M |
Cash Acquisitions | -3.23M | -3.23M | -- | -- | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -2.31M | -2.30M | -3.03M | -904.00K | -1.40M |
Cash from Investing | -19.61M | -25.81M | -29.59M | -44.59M | -59.65M |
Total Debt Issued | 0.00 | 20.18M | 20.18M | 20.18M | 20.18M |
Total Debt Repaid | -4.45M | -4.58M | -4.51M | -4.19M | -3.84M |
Issuance of Common Stock | 9.00K | 9.00K | 2.00K | -- | 0.00 |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -200.00K | -- | -- | -- | -- |
Other Financing Activities | -28.59M | -36.32M | -40.08M | -42.90M | -41.49M |
Cash from Financing | -33.23M | -20.71M | -24.42M | -26.91M | -25.16M |
Foreign Exchange rate Adjustments | -69.00K | -37.00K | -50.00K | -62.00K | 3.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 46.79M | 44.39M | 37.70M | -12.99M | -19.30M |